News

AbstractThis electronic health record-based study highlights distinct diagnostic patterns preceding a diagnosis of light chain (AL) and wild-type transthyretin (…

AbstractBackground: Amyloidosis is an infiltrative cardiomyopathy caused by amyloid deposition into the myocardium. In recent years, recognition of this treatable…

AbstractHereditary transthyretin amyloidosis (ATTRv), the most common form of hereditary amyloidosis, results from autosomal dominant mutations in the TTR gene.…

AbstractBackground Bone-avid tracer myocardial scintigraphy for the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) has traditionally employed imaging…

With the determination of the President no. 655/2026 (Rome, 21 May 2026; published in the Official Gazette on 28 May 2026), the Italian Medicines Agency extended…

AbstractIntroductionTransthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease predominantly affecting older men and is associated with increasing care…

AbstractBackground Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a rare, life‐threatening form of restrictive cardiomyopathy. Access to cardiology providers and…

AbstractBackgroundThe Mayo transthyretin amyloid cardiomyopathy (ATTR-CM) and AMY scores were developed to identify patients at risk for ATTR-CM. However, both were…

For women living with ATTR-Cardiac Amyloidosis (ATTR-CM), a serious heart disease that worsens over time, the path to diagnosis is rarely straightforward. Symptoms…

AbstractSystemic light chain (AL) amyloidosis is a rare, acquired protein misfolding disorder characterized by extracellular deposition of misfolded immunoglobulin…